Which has grown faster, CAI or CYTK?

Over the past five years, CAI grew revenue faster — CAI at a 26.15% CAGR versus CYTK at 4.19%.

Is CAI or CYTK more profitable?

CAI runs the higher net margin — CAI at 10.62% versus CYTK at -1259.87%.

Caris Life Sciences, Inc. (CAI) vs Cytokinetics, Incorporated (CYTK)

A side-by-side comparison of Caris Life Sciences, Inc. and Cytokinetics, Incorporated across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CAI

Caris Life Sciences, Inc.

$8.00B

$28.29HealthcareDelayed quote: Oct 6, 2026, 1:05 PM EDT

CYTK

Cytokinetics, Incorporated

$7.60B

$61.10HealthcareDelayed quote: Oct 6, 2026, 1:05 PM EDT

Total return — CAI vs CYTK

growth of $100 · dividends reinvested · last 1y

CAI +8.5% (+8.5%/yr)CYTK +85.6% (+85.6%/yr)CYTK compounded faster over this window

CAI CYTK

CAI vs CYTK: by the numbers

•CAI is the larger company ($8.00B vs $7.60B market cap).
•CAI is profitable (10.62% net margin) while CYTK runs a net loss (-1259.87%).
•CAI grew revenue faster over the past five years (26.15% vs 4.19% CAGR).

Metrics side by side

Valuation

Metric	CAI	CYTK
P/E ratio	79.04	N/A
Forward P/E	243.79	N/A
P/S ratio	8.08	107.14
P/B ratio	13.51	N/A
EV / EBITDA	44.58	N/A
FCF yield	1.83%	N/A

Profitability

Metric	CAI	CYTK
Gross margin	69.66%	84.97%
Operating margin	5.56%	-695.44%
Net margin	10.62%	-1259.87%
ROE	17.77%	N/A
ROIC	14.76%	-39.80%

Growth (annualized)

Metric	CAI	CYTK
Revenue CAGR (5Y)	26.15%	4.19%
Total return CAGR (5Y)	N/A	11.24%

Frequently asked

Which has grown faster, CAI or CYTK?: Over the past five years, CAI grew revenue faster — CAI at a 26.15% CAGR versus CYTK at 4.19%.
Is CAI or CYTK more profitable?: CAI runs the higher net margin — CAI at 10.62% versus CYTK at -1259.87%.

Go deeper

Full CAI analysis Full CYTK analysis Interactive comparison tool

Dig into the metrics

Caris Life Sciences P/E ratio Caris Life Sciences ROE Cytokinetics ROE Caris Life Sciences operating margin Cytokinetics operating margin Caris Life Sciences revenue growth Cytokinetics revenue growth Caris Life Sciences free cash flow Cytokinetics free cash flow

Caris Life Sciences & Cytokinetics appear in these rankings

Fastest Revenue Growth Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.